Home › Lymphoma › Utah › Salt Lake City

Pag-aaral pangklinika para sa Lymphoma sa Salt Lake City, UT

Isang pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Salt Lake City. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Nagre-recruitPhase 1/2

Intermountain Health, Canyons Region, LDS Hospital, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06343311

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

Nagre-recruit

Huntsman Cancer Institute, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07013435

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Nagre-recruitPhase 2

University of Utah, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07221500

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Nagre-recruitPhase 1/2

Primary Children's Hospital, Salt Lake City

12 Months – 21 Years · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04870944

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Huntsman Cancer Institute, Salt Lake City
Intermountain Healthcare, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Nagre-recruitPhase 3

Intermountain Healthcare, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 4, 2026 · NCT07188558

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

Nagre-recruitObservasyonal na pag-aaral

Huntsman Cancer Institute, University of Utah, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 1, 2026 · NCT05663502

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Nagre-recruitPhase 1/2

Huntsman Cancer Institute, University of Utah, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT03328078

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Nagre-recruitPhase 1

Huntsman Cancer Institute, University of Utah, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Mar 20, 2026 · NCT04830137

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

Nagre-recruit

Huntsman Cancer Institute at University of Utah, Salt Lake City

Edad 21 pataas · Lahat ng kasarian · Na-update Peb 5, 2026 · NCT07390071

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Nagre-recruitPhase 1/2

University of Utah, Salt Lake City

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 14, 2025 · NCT05643742

Pag-aaral para sa Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Salt Lake City

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.